Hypercholesterolemia and atherosclerosis: present and future therapy including LDL-apheresis. 1988

B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
Cardiovascular Research Unit, Mayo Clinic, Rochester, Minnesota 55903.

Atherosclerosis-induced coronary heart disease remains the major cause of death and disability in industrialized countries. Hypercholesterolemia is recognized as a causative factor in the development of atherosclerosis. While the lowering of cholesterol levels as a treatment goal has met with general agreement and acceptance, the preferred methods for doing so are still open to conjecture. This literature review discusses various factors in the hypercholesterolemia-atherosclerosis link and surveys a variety of treatment protocols including diet modification, drug therapy, surgical intervention, and plasmapheresis. Evidence is accumulating to prove that the ideal hypercholesterolemia therapy is one that reduces LDL levels while maintaining or increasing HDL levels. Because LDL-apheresis has this potential, this paper also reviews the various LDL-apheresis methods, including immunoadsorption, chemical affinity, and double-membrane filtration.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D009316 National Institutes of Health (U.S.) An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. United States National Institutes of Health,National Institutes of Health
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
October 2005, The International journal of artificial organs,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
May 1985, Lancet (London, England),
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
November 2014, Vnitrni lekarstvi,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
January 1988, Beitrage zur Infusionstherapie = Contributions to infusion therapy,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
August 2006, Current treatment options in cardiovascular medicine,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
September 2012, Scandinavian journal of immunology,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
January 1994, Annales de medecine interne,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
October 2011, Lipids in health and disease,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
October 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
B A Kottke, and A A Pineda, and M T Case, and A M Orsuzar, and K A Brzys
January 1985, La Ricerca in clinica e in laboratorio,
Copied contents to your clipboard!